Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Devogelaere Vision
Provided the inclusion criteria were met, RVP measurement was repeated, and a 1 capsule/day regimen of Ocufolin® forte was subsequently carried out for a duration of 3 months, after which repeat measurements of IOP, SSpERG, and RVP were performed, along with dilated fundoscopy. .
Age
Any age
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
glaucoma and/or ocular vascular disease in at least on eye
abnormal SSpERG
RVP measured using an ophthalmodynamometer at least 15 mmHg higher than intra-ocular pressure (IOP),
fasting serum Hcy level \> 12 µmol/l
stable and well-controlled IOP (with or without IOP-lowering treatment)
You may not be if
starting other systemic or ocular medications with potential impacts on RVP within a month before entering the study or during the course of the study
starting or changing the dosage of other medications with potential impact on SSpERG within 3 months before entering the study or during the course of the study
non-adherence to the follow-up schedule
inability to perform a proper RVP measurement using ophthalmodynamometry.